التفاصيل البيبلوغرافية
| العنوان: |
1421MO Final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma |
| المؤلفون: |
Al-Batran, S-E., Haag, G.M., Ettrich, T.J., Borchert, K., Kretzschmar, A., Teschendorf, C., Siegler, G.M., Ebert, M., Goekkurt, E., Welslau, M.K., Mahlberg, R.J.C., Homann, N., Pink, D., Bechstein, W.O., Reichardt, P., Gaiser, T., Sookthai, D., Pauligk, C., Goetze, T.O., Hofheinz, R.D. |
| المصدر: |
In Annals of Oncology September 2020 31 Supplement 4:S899-S899 |
| قاعدة البيانات: |
ScienceDirect |
